"We did not meet our financial goals in 2024, and that's reflected in our corporate bonus," a company representative told ...
Companies inform investors of possible business risks from Trump's government changes, tucking warnings into extensive "risk ...
CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim ...
President Trump's government overhaul in annual reports, highlighting risks from tariffs to healthcare reforms.
Before serving as interim president at Caremark, DeVaney led sales and account management as president of employer and health ...
2d
Barchart on MSNThis Dividend Stock Is Up 45% in 2025. Is It Too Late to Buy Shares Now?Detailed price information for Unitedhealth Group Inc (UNH-N) from The Globe and Mail including charting and trades.
3don MSN
The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.
In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management ...
Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.
Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...
In this article, we will look at the 10 Best Performing Healthcare Stocks So Far in 2025.
CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results